Immunotherapy in NMSC: Bringing the Data to Life

Program Overview

This activity features an interprofessional, multidisciplinary panel of experts offering privileged insights on immunotherapy in advanced cutaneous squamous cell carcinoma (CSCC) and basal cell carcinoma (BCC). Uniquely, this evidence-based discussion is augmented by perspectives from a patient panelist sharing key aspects of their own treatment journey.

Credit Expired

Target Audience

Medical oncology and dermatology clinicians

Educational Objectives

Upon completion of this activity, participants should be better able to:

Assess current clinical evidence for immunotherapy-based treatment of advanced nonmelanoma skin cancers (NMSC)
Integrate immunotherapy in the management of advanced CSCC and BCC